CymaBay Therapeutics, Inc. Quarterly Interest Expense in USD from Q3 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
CymaBay Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2012 to Q4 2023.
  • CymaBay Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2023 was $5.08M, a 24.7% increase year-over-year.
  • CymaBay Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2023 was $18.9M, a 27.1% increase year-over-year.
  • CymaBay Therapeutics, Inc. annual Interest Expense for 2023 was $18.9M, a 27.1% increase from 2022.
  • CymaBay Therapeutics, Inc. annual Interest Expense for 2022 was $14.9M, a 477% increase from 2021.
  • CymaBay Therapeutics, Inc. annual Interest Expense for 2021 was $2.58M.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $18.9M $5.08M +$1.01M +24.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $17.9M $4.84M +$1.02M +26.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $16.9M $4.62M +$970K +26.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $15.9M $4.4M +$1.04M +30.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $14.9M $4.08M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $3.82M +$3.3M +632% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $3.65M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $3.37M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $522K +$522K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2018 $828K $128K -$155K -54.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $983K $208K -$97K -31.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $1.08M $234K -$94K -28.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 $1.17M $258K -$83K -24.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $1.26M $283K -$53K -15.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.31M $305K -$27K -8.13% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $1.34M $328K -$1K -0.3% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $1.34M $341K +$76K +28.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $1.26M $336K +$171K +104% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $1.09M $332K +$178K +116% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $913K $329K +$138K +72.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-23
Q3 2015 $775K $265K +$74K +38.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $701K $165K -$24K -12.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $725K $154K -$30K -16.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 $755K $191K +$9K +4.95% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-29
Q3 2014 $746K $191K -$28K -12.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $774K $189K -$20K -9.57% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $794K $184K -$28K -13.2% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $822K $182K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-23
Q3 2013 $219K -$1K -0.46% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $209K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 $212K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q3 2012 $220K Jul 1, 2012 Sep 30, 2012 10-Q/A 2013-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.